News

Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results

August 14, 2018

REDWOOD CITY, Calif. , Aug. 14, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...

Read More

Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome

July 30, 2018

Phase III Clinical Trial Ongoing at Multiple Sites in the U.S. REDWOOD CITY, Calif. , ...

Read More

Soleno Therapeutics To Present Corporate Update at the BIO International Convention

June 04, 2018

REDWOOD CITY, Calif. , June 04, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ:SLNO), a clinical-stage ...

Read More
Soleno – Home